Patent Assignment
Reel/Frame 029218/0709
Assignment of Assignor's Interest
Recorded: 2012-10-31
Pages: 7
Assignor
CHEMGENEX PHARMACEUTICALS PTY LTD
Executed: 2012-03-12
Assignee
IVAX INTERNATIONAL GMBH
ALPENSTRASSE 2, RAPPERSWIL, 8640, SWITZERLAND
Covered Property
(1)
Treatment of Chronic Myelogenous Leukemia, Resistant or Intolerant to ST1571, Involving Homoharringtonine Alone or Combined with Other Agents
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2003
From: ROBIN, JEAN-PIERRE; MAHON, FRANCOIS-XAVIER; MAISONNEUVE, HERVE; MALOISEL, FREDERICK
To: ONCOPHARM CORPORATION
Reel/Frame 014793/0809 →
Assignment of Assignor's Interest
Aug 19, 2004
From: ONCOPHARM CORPORATION
To: ONCOPHARM SAS
Reel/Frame 015074/0095 →
Assignment of Assignor's Interest
Aug 19, 2004
From: ONCOPHARM SAS
To: STRAGEN PHARMA SA
Reel/Frame 015074/0090 →
Assignment of Assignor's Interest
Aug 27, 2009
From: STRAGEN PHARMA S.A.
To: CHEMGENEX PHARMACEUTICALS LTD.
Reel/Frame 023148/0315 →
Change of Name
Dec 5, 2016
From: IVAX INTERNATIONAL GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 040831/0020 →
Commercial Register Changes
Sep 18, 2017
From: IVAX PHARMACEUTICALS GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 043889/0617 →
Change of Name
Nov 3, 2017
From: CHEMGENEX PHARMACEUTICALS LTD
To: CHEMGENEX PHARMACEUTICALS PTY LTD
Reel/Frame 044366/0250 →
Corrective Assignment to Correct the Assignor Name Previously Recorded at Reel: 043889 Frame: 0617. Assignor(S) Hereby Confirms the Change of Nane.
Nov 3, 2017
From: IVAX INTERNATIONAL GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 044710/0595 →